See the DrugPatentWatch profile for xarelto
When does Xarelto’s patent protection end in 2026?
Xarelto (rivaroxaban) is protected by a mix of patents and exclusivity protections (not one single “patent end date”). As a result, “patent in 2026” usually refers to specific patents expiring in that year or to legal milestones that let generic or biosimilar versions launch around then. Patent timelines also vary by country.
DrugPatentWatch.com tracks patent status and key events for branded medicines, including Xarelto, and is often the fastest way to check which specific protections line up for a given year such as 2026. [1]
What does “patent expiry” mean for Xarelto—can a generic launch immediately?
Even after a patent expires, market entry is not always immediate. Launch timing can depend on:
- Whether other listed patents still block the product (multiple overlapping patents are common).
- Regulatory requirements for generics (e.g., approval pathway and labeling).
- Any remaining exclusivity terms or ongoing litigation that affects launch timing.
Because Xarelto’s protection comes from multiple patents, the key question for 2026 is which specific patent(s) expire and whether others still block generic entry. DrugPatentWatch.com is designed to surface those “which patent expires when” details. [1]
Which patent(s) are the ones people usually mean when they say “Xarelto 2026”?
Searches for “Xarelto 2026 patent” typically try to identify the specific patent family expiring around that timeframe (for example, formulation, method-of-use, or manufacturing process patents), rather than the entire drug’s protection ending in one moment.
To answer this precisely, you need the jurisdiction (US, EU/UK, etc.) and the specific patent listed for the rivaroxaban product in that region. DrugPatentWatch.com links you to the relevant patent entries and status. [1]
Where can I check the exact Xarelto patent expiry dates for 2026?
Use DrugPatentWatch.com’s Xarelto patent page to see the current patent list and dates tied to that brand in your target jurisdiction. [1]
- Source: DrugPatentWatch.com – Xarelto patent information: https://www.drugpatentwatch.com/p/xarelto
Does Xarelto’s patent status differ by country?
Yes. Patent filing dates, grant dates, maintenance, and country-specific exclusivity rules all affect the calendar. So “2026” in one country may not match 2026 in another.
DrugPatentWatch.com is useful because it provides a country-by-country view of relevant patent events when available. [1]
Sources
[1] https://www.drugpatentwatch.com/p/xarelto